Pressreleases

Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors

Tosoh Bioscience, a leading provider of chromatographic solutions for biomolecule separation and purification, announced a pioneering partnership with Prof Dr Michael Wolff from the University of Applied Sciences Mittelhessen (THM), Gießen, Germany, which will focus on developing continuous purification processes for viruses and viral vectors. This collaboration aligns with Tosoh Bioscience’s efforts to support the cell and gene therapy (CGT) industry and researchers worldwide.

New Part Number and Batch Number Marking Position on Filter Elements – Use and Installation Instructions

BEA Technologies, following its innovative spirit, has improved the marking of the filer elements, making it more readable. The transition has been made from a CO₂ laser marking on the band to a marking using green wave laser source carried out on the cap or on the ends of the filter elements.

Gerresheimer Expands Capacities for Medical Systems in the USA

Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, is significantly expanding its production capacities for medical systems such as inhalers and autoinjectors in the United States. In two expansion stages, Gerresheimer is expanding the production area at its Peachtree City site in the state of Georgia, USA, by around 18,000m² (194,000ft²).

Gerresheimer to Acquire Blitz Lux, the Holding Company of the Bormioli Pharma Group – Strategic Reset of Moulded Glass Business

Gerresheimer Glas, an indirect subsidiary of Gerresheimer, has today signed a purchase agreement with funds advised by Triton for the acquisition of Blitz Lux, the holding company of the Bormioli Pharma Group. The purchase price is based on a determined enterprise value of around €800m, which corresponds to an adjusted EBITDA multiple of around ten.

Gerresheimer Partners with RxCap to Offer Connected Adherence Solutions

Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has entered into a partnership with the US digital health company RxCap and acquired a minority stake. Under the terms of the agreement, Gerresheimer's subsidiary Centor will receive the exclusive distribution rights for pharmacies in the US for adherence solutions by RxCap, consisting of connected prescription vial closure devices and complementary cloud-based software. Centor is the US market leader in prescription vials and is uniquely positioned to enable smart adherence solutions through existing pharmacy workflows.

Gerresheimer Makes Solid Start to the Financial Year 2024

Gerresheimer, an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries, continued its profitable growth trajectory in the first quarter of 2024 with organic revenue growth of 2.8% and an organic increase in adjusted EBITDA of 5.9%. This positive development was fueled primarily by the performance of the Plastics & Devices Division. Revenues came to € 466.1m (Q1 2023: € 457.8m), with adjusted EBITDA standing at €80.9m (Q1 2023: €78.0m). The adjusted EBITDA margin improved organically by 50 basis points to 17.3% year on year (Q1 2023: 16.8%).

Gerresheimer Performance Levels Simplify Choice of Optimum Solution

Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, presents its new performance levels for injection vials, syringes, cartridges and ampoules. Within the relevant product category, customers can choose from three performance levels: Gx Value, Gx Advance and Gx Elite. The new structure makes it easier to select the right product platform according to the requirements for the pharmaceutical active agent or area of application. Gx Elite products offer the highest performance and are especially suitable for innovative biopharmaceutical products.

Sofgen Pharmaceuticals to Exhibit at CPhI North America 2024

Sofgen Pharmaceuticals is an integrated CDMO/CMO that offers end-to-end from development throughout delivery for prescription drugs, OTC products and specialized nutraceuticals in Softgel advanced technologies.

Molnar Institute at Analytica 2024 – 9-12 April in Munich, Germany

Molnar Institute, a company focused on improving the efficiency and success of modern high-performance liquid chromatography (HPLC), will be exhibiting at this year's Analytica trade show taking place in Munich, Germany, from 9-12 April.